News & Articles

Study suggests our organs may have their own sexual identity

The key to fighting cancer in many cases is early detection, and earlier detection at the cellular level could mean survival for many cancer patients

Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.

GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine

Novel strategy shortens time to heart attack diagnosis drastically, enabling faster start of treatment of patients and better use of healthcare resources

Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening

Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions

Roche Presents Updated Results for Investigational Cancer Immunotherapy Atezolizumab in Advanced Bladder Cancer

Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma

Protagen Supports Novel Route to Serum Based Prostate Cancer Diagnostics

The SelectScience article library contains downloads on the very latest technologies being used in cancer research and diagnostics

Hear from the winner of the Best New Drug Discovery Product of 2015, Thermo Fisher Scientific

Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection

Scientifica Launches First US Office

New clinical biomarkers have the potential to greatly improve our understanding of cancer

Discover the winning product, voted for by scientists worldwide

Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays

written by Luminex

Third offering in Quest's precision medicine menu for oncology immunotherapies

Are amyloid plaques the best therapeutic target?

SelectScience® and The Society for Laboratory Automation and Screening form a new partnership

Promega NanoLuc Enables a First in Measuring Drug-Target Residence in Live Cells

Featured products will include the new BioSpa™ 8, Cytation™ 5 and Synergy™ Neo2